Sanara MedTech Inc. (SMTI) stock
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.73+0.00 (0.00%)
Close on Nov 18, 2026Market cap $300.72MP/E –Yield –
Sanara MedTech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Sanara MedTech's operating income for the twelve months ending Jun 30, 2026 was $8.42M, up 32.5% year over year. For fiscal 2025 it was $7.30M, up 480.3% from the year before. The highest annual figure on record is $7.30M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.30M | +480.3% |
| FY2024 | Dec 31, 2024 | $1.26M | – |
| FY2023 | Dec 31, 2023 | -$4.22M | – |
| FY2022 | Dec 31, 2022 | -$12.52M | – |
| FY2021 | Dec 31, 2021 | -$7.38M | – |
| FY2020 | Dec 31, 2020 | -$5.03M | – |
| FY2019 | Dec 31, 2019 | -$2.74M | – |
| FY2018 | Dec 31, 2018 | -$501.86K | -516.7% |
| FY2017 | Dec 31, 2017 | $120.44K | – |
| FY2016 | Dec 31, 2016 | -$272.13K | – |
| FY2015 | Dec 31, 2015 | -$964.98K | – |
| FY2011 | Dec 31, 2011 | -$5.01M | – |
| FY2010 | Dec 31, 2010 | -$2.48M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.78M | -28.4% |
| Q1 FY2026 | Mar 31, 2026 | $2.65M | +220.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.05M | -53.5% |
| Q3 FY2025 | Sep 30, 2025 | $2.94M | +277.8% |
| Q2 FY2025 | Jun 30, 2025 | $2.49M | – |
| Q1 FY2025 | Mar 31, 2025 | $825.53K | – |
| Q4 FY2024 | Dec 31, 2024 | $2.26M | – |
| Q3 FY2024 | Sep 30, 2024 | $778.54K | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.88M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$226.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$906.66K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.22M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.12M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.23M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.38M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.78M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.41M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.85M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.03M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.08M | – |
| Q4 FY2020 | Dec 31, 2020 | -$852.06K | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.31M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.08M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.80M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.46M | – |
| Q3 FY2019 | Sep 30, 2019 | -$797.22K | – |
| Q2 FY2019 | Jun 30, 2019 | -$323.13K | -1143.0% |
| Q1 FY2019 | Mar 31, 2019 | -$157.15K | -335.6% |
| Q4 FY2018 | Dec 31, 2018 | -$467.55K | – |
| Q3 FY2018 | Sep 30, 2018 | -$132.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $30.98K | -73.9% |
| Q1 FY2018 | Mar 31, 2018 | $66.71K | +14.5% |
| Q4 FY2017 | Dec 31, 2017 | -$27.76K | -110.0% |
| Q3 FY2017 | Sep 30, 2017 | -$28.78K | -113.3% |
| Q2 FY2017 | Jun 30, 2017 | $118.72K | – |
| Q1 FY2017 | Mar 31, 2017 | $58.26K | – |
| Q4 FY2016 | Dec 31, 2016 | $276.65K | – |
| Q3 FY2016 | Sep 30, 2016 | $216.15K | – |
See a number that looks wrong?